Phibro Animal Health (PAHC) FCF Payout Ratio Growth (1y) (2015 - 2026)
Phibro Animal Health (PAHC) FCF Payout Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | 15.81% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -130.26% |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 37.82% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.34 Bn | 125.68 Mn | -15.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.35% |
| Dec 31, 2025 | 12.78% |
| Sep 30, 2025 | -66.93% |
| Jun 30, 2025 | 89.01% |
| Mar 31, 2025 | -95.26% |
| Dec 31, 2024 | -380.47% |
| Sep 30, 2024 | 426.75% |
| Jun 30, 2024 | -39.14% |
| Mar 31, 2024 | 2,227.11% |
| Dec 31, 2023 | 63.19% |
| Sep 30, 2023 | 311.61% |
| Jun 30, 2023 | 154.36% |
| Mar 31, 2023 | 89.11% |
| Dec 31, 2022 | -42.78% |
| Sep 30, 2022 | 89.29% |
| Jun 30, 2022 | -1.59% |
| Mar 31, 2022 | -46.74% |
| Dec 31, 2021 | 119.18% |
| Sep 30, 2021 | -141.20% |
| Jun 30, 2021 | 223.24% |